Naoto Hashizume Selected Research

Naoto Hashizume Research Topics

15	Myocardial Infarction 08/2023 - 01/2015
11	Stroke (Strokes) 08/2023 - 01/2016
8	Heart Failure 10/2021 - 03/2017
7	Coronary Artery Disease (Coronary Atherosclerosis) 08/2023 - 01/2016
3	Peripheral Arterial Disease 01/2022 - 06/2017
3	Hemorrhage 03/2021 - 03/2017
2	Inflammation (Inflammations) 03/2023 - 10/2018
2	Atrial Fibrillation 10/2021 - 07/2017
2	Chronic Renal Insufficiency 10/2021 - 01/2016
2	Death (Near-Death Experience) 02/2019 - 07/2017
2	Acute Coronary Syndrome 01/2019 - 03/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 01/2015
1	Acute Kidney Injury (Acute Renal Failure) 10/2021
1	Myocarditis (Carditis) 10/2018
1	Cardiac Arrhythmias (Arrythmia) 10/2018
1	Renal Insufficiency (Renal Failure) 08/2017
1	Thrombosis (Thrombus) 07/2017
1	Shock 04/2017
1	Atherosclerosis 01/2017
1	Ischemic Stroke 01/2015

14	omega-Chloroacetophenone (Mace)IBA 08/2023 - 01/2015
2	Serum AlbuminIBA 08/2021 - 01/2019
2	Hemoglobins (Hemoglobin)IBA 08/2021 - 01/2016
1	Cilostazol (Pletal)FDA LinkGeneric 01/2022
1	CreatinineIBA 08/2021
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 08/2021
1	Brain Natriuretic Peptide (Natrecor)FDA Link 08/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2021
1	Mineralocorticoid Receptor AntagonistsIBA 10/2020
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 02/2019
1	azosemideIBA 02/2019
1	Prednisolone (Predate)FDA LinkGeneric 10/2018
1	Furosemide (Lasix)FDA LinkGeneric 10/2018
1	CatecholaminesIBA 10/2018
1	Type 3 Cyclic Nucleotide PhosphodiesterasesIBA 10/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2018
1	Atrial Natriuretic Factor (ANF)IBA 10/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2017
1	Ezetimibe (Zetia)FDA Link 09/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2015

8	Percutaneous Coronary Intervention 10/2021 - 01/2016
4	Therapeutics 03/2021 - 09/2015
1	Palliative Care (Palliative Therapy) 03/2020
1	Stents 07/2017
1	Drug-Eluting Stents 07/2017
1	Renal Dialysis (Hemodialysis) 01/2016
1	Secondary Prevention 09/2015